Filing Details
- Accession Number:
- 0000950170-24-015564
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-14 21:12:29
- Reporting Period:
- 2024-02-12
- Accepted Time:
- 2024-02-14 21:12:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1787400 | Nkarta Inc. | NKTX | Pharmaceutical Preparations (2834) | 474515206 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1816549 | James Trager | C/O Nkarta, Inc. 1150 Veterans Boulevard South San Francisco CA 94080 | Chief Scientific Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-02-12 | 4,143 | $12.00 | 149,415 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The transaction reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person and most recently amended on June 22, 2022.
Billionaire Hedge Funds
